Altered fibroblast proteoglycan production in COPD

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Hallgren, Oskar ^a,b   Nihlberg, Kristian ^a   Dahlbäck, Magnus ^c   Bjermer, Leif ^b   Eriksson, Leif T ^c   Erjefält, Jonas S ^a   Löfdahl, Claes Göran ^b   Westergren Thorsson, Gunilla ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PERLECAN; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; VERSICAN; BIGLYCAN; DECORIN; PROTEOHEPARAN SULFATE; SCLEROPROTEIN; VCAN PROTEIN, HUMAN;

ADULT; AGED; AIRWAY; ARTICLE; BASEMENT MEMBRANE; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROBLAST; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IN VITRO STUDY; LUNG PARENCHYMA; MALE; PHENOTYPE; CASE CONTROL STUDY; CELL CULTURE; HOSPITALIZATION; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; PROTEOGLYCANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1; VERSICANS; YOUNG ADULT;

EID: 77956672918     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-55     Document Type: Article

References (37)

1. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22(4):672-688. 10.1183/09031936.03.00040703, 14582923.
2. Chrzanowski P, Keller S, Cerreta J, Mandl I, Turino GM. Elastin content of normal and emphysematous lung parenchyma. Am J Med 1980, 69(3):351-359. 10.1016/0002-9343(80)90004-2, 7416182.
3. Nakano Y, Muller NL, King GG, Niimi A, Kalloger SE, Mishima M, Pare PD. Quantitative assessment of airway remodeling using high-resolution CT. Chest 2002, 122(6 Suppl):271S-275S.
4. Tiddens HA, Pare PD, Hogg JC, Hop WC, Lambert R, de Jongste JC. Cartilaginous airway dimensions and airflow obstruction in human lungs. Am J Respir Crit Care Med 1995, 152(1):260-266.
5. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(26):2645-2653. 10.1056/NEJMoa032158, 15215480.
6. Kotaru C, Schoonover KJ, Trudeau JB, Huynh ML, Zhou X, Hu H, Wenzel SE. Regional fibroblast heterogeneity in the lung: implications for remodeling. Am J Respir Crit Care Med 2006, 173(11):1208-1215. 10.1164/rccm.200508-1218OC, 2662967, 16543551.
7. Pechkovsky DV, Hackett TL, An SS, Shaheen F, Murray LA, Knight DA. Human Lung Parenchyma but not Proximal Bronchi Produces Fibroblasts with Enhanced TGF{beta} Signaling and {alpha}SMA Expression. Am J Respir Cell Mol Biol
8. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000, 342(18):1350-1358. 10.1056/NEJM200005043421807, 10793168.
9. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. Faseb J 2004, 18(7):816-827. 10.1096/fj.03-1273rev, 15117886.
10. Merrilees MJ, Ching PS, Beaumont B, Hinek A, Wight TN, Black PN. Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res 2008, 9:41. 10.1186/1465-9921-9-41, 2397404, 18485243.
11. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman HF, Timens W, Postma DS. Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 1999, 12(7):697-705.
12. Malmstrom J, Larsen K, Hansson L, Lofdahl CG, Norregard-Jensen O, Marko-Varga G, Westergren-Thorsson G. Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2002, 2(4):394-404. 10.1002/1615-9861(200204)2:4<394::AID-PROT394>3.0.CO;2-6, 12164698.
13. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986, 159(1):109-113. 10.1016/0003-2697(86)90314-3, 3812988.
14. Westergren-Thorsson G, Persson S, Isaksson A, Onnervik PO, Malmstrom A, Fransson LA. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp Cell Res 1993, 206(1):93-99. 10.1006/excr.1993.1124, 7683278.
15. Tufvesson E, Westergren-Thorsson G. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha. J Cell Biochem 2000, 77(2):298-309. 10.1002/(SICI)1097-4644(20000501)77:2<298::AID-JCB12>3.0.CO;2-D, 10723095.
16. Chiavegato A, Roelofs M, Franch R, Castellucci E, Sarinella F, Sartore S. Differential expression of SM22 isoforms in myofibroblasts and smooth muscle cells from rabbit bladder. J Muscle Res Cell Motil 1999, 20(2):133-146. 10.1023/A:1005411201187, 10412085.
17. Holz O, Zuhlke I, Jaksztat E, Muller KC, Welker L, Nakashima M, Diemel KD, Branscheid D, Magnussen H, Jorres RA. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004, 24(4):575-579. 10.1183/09031936.04.00143703, 15459135.
18. Noordhoek JA, Postma DS, Chong LL, Vos JT, Kauffman HF, Timens W, van Straaten JF. Different proliferative capacity of lung fibroblasts obtained from control subjects and patients with emphysema. Exp Lung Res 2003, 29(5):291-302. 10.1080/01902140303789, 12746043.
19. Nobukuni S, Watanabe K, Inoue J, Wen FQ, Tamaru N, Yoshida M. Cigarette smoke inhibits the growth of lung fibroblasts from patients with pulmonary emphysema. Respirology 2002, 7(3):217-223. 10.1046/j.1440-1843.2002.00400.x, 12153687.
20. Tufvesson E, Westergren-Thorsson G. Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. J Cell Sci 2003, 116(Pt 23):4857-4864. 10.1242/jcs.00808, 14600270.
21. Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC. Transforming growth factor beta 1 gene expression in human airways. Thorax 1994, 49(3):225-232. 10.1136/thx.49.3.225, 1021150, 8202878.
22. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, Umeda A. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001, 163(6):1476-1483.
23. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997, 156(2 Pt 1):591-599.
24. Itoh S, Itoh F, Goumans MJ, Ten Dijke P. Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem 2000, 267(24):6954-6967. 10.1046/j.1432-1327.2000.01828.x, 11106403.
25. Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 2004, 35(2):83-92. 10.1016/j.jdermsci.2003.12.006, 15265520.
26. Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, Kawasaki S, Ahn Y, Fredriksson K, Skold CM, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008, 178(3):248-260. 10.1164/rccm.200706-929OC, 2542423, 18467512.
27. Zandvoort A, Postma DS, Jonker MR, Noordhoek JA, Vos JT, Timens W. Smad gene expression in pulmonary fibroblasts: indications for defective ECM repair in COPD. Respir Res 2008, 9:83. 10.1186/1465-9921-9-83, 2613883, 19087346.
28. Huang R, Merrilees MJ, Braun K, Beaumont B, Lemire J, Clowes AW, Hinek A, Wight TN. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 2006, 98(3):370-377. 10.1161/01.RES.0000202051.28319.c8, 16385080.
29. Merrilees MJ, Lemire JM, Fischer JW, Kinsella MG, Braun KR, Clowes AW, Wight TN. Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ Res 2002, 90(4):481-487. 10.1161/hh0402.105791, 11884379.
30. Knox SM, Whitelock JM. Perlecan: how does one molecule do so many things?. Cell Mol Life Sci 2006, 63(21):2435-2445. 10.1007/s00018-006-6162-z, 16952056.
31. Costell M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, Munoz-Chapuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 2002, 91(2):158-164. 10.1161/01.RES.0000026056.81424.DA, 12142349.
32. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 1999, 147(5):1109-1122. 10.1083/jcb.147.5.1109, 2169352, 10579729.
33. Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005, 97(11):1093-1107. 10.1161/01.RES.0000191547.64391.e3, 16306453.
34. Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993, 92(2):632-637. 10.1172/JCI116631, 294895, 7688761.
35. Westergren-Thorsson G, Sime P, Jordana M, Gauldie J, Sarnstrand B, Malmstrom A. Lung fibroblast clones from normal and fibrotic subjects differ in hyaluronan and decorin production and rate of proliferation. Int J Biochem Cell Biol 2004, 36(8):1573-1584. 10.1016/j.biocel.2004.01.009, 15147736.
36. Feyzi E, Saldeen T, Larsson E, Lindahl U, Salmivirta M. Age-dependent modulation of heparan sulfate structure and function. J Biol Chem 1998, 273(22):13395-13398. 10.1074/jbc.273.22.13395, 9593669.
37. Nomura Y. Structural change in decorin with skin aging. Connect Tissue Res 2006, 47(5):249-255. 10.1080/03008200600846606, 17118746.